A study of the purinoceptors mediating contraction in the rat colon
Open Access
- 1 August 1990
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 100 (4) , 753-756
- https://doi.org/10.1111/j.1476-5381.1990.tb14087.x
Abstract
1 The effects of a number of purine analogues were examined on the rat isolated colon muscularis mucosae. Adenosine, adenosine 5′-monophosphate (AMP), adenosine 5′-diphosphate (ADP), adenosine 5′-triphosphate (ATP), 2-methylthioATP (MeSATP), adenosine 5′-(2-fluorodiphosphate) (ADPβF), adenosine 5′-(β,γ-methylene)triphosphonate (AM PPCP) and adenosine 5′-(α,β-methylene)triphosphonate (AMPCPP) each contracted the muscularis mucosae in the concentration range 1–100 μm. 2 MeSATP was the most potent purine agonist, with a threshold concentration for contraction of 0.05 μm and an EC50 of approximately 0.3 μm, and AMPCPP was less potent than ATP. The enantiomer of AMPPCP, l-AMPPCP, was inactive at concentrations up to 100 μm. 3 The adenosine receptor antagonist 8-(p-sulphophenyl)theophylline (8-SPT, 50 μm) produced approximately 50 fold shifts of the dose-response curves to adenosine, AMP and AMPPCP, whereas those to ATP, MeSATP and substance P (SP) were unaffected. Intermediate shifts were observed for the dose-response curves to ADP, AD$1βF and AMPCPP. With a lower concentration of 8-SPT (10 μm) a dose ratio of approximately 11 was observed for the inhibition of the effects of both adenosine and AMPPCP. 4 ATP was rapidly degraded by the tissue to ADP, AMP and adenosine, AD$1βF was more slowly degraded to AMP and adenosine, and no significant degradation of AMPPCP was detected during 20 min incubation. 5 The results are consistent with the existence in the rat colon muscularis mucosae of a mixed population of purine receptors of P2Y and P1 types. The colon thus contains the first documented incidence of a P2Y-receptor mediating contraction. The powerful inhibition by the P1-purinoceptor antagonist 8-SPT of the effects of AMPPCP suggests that its action in this tissue is mediated by P1-purinoceptors, although 8-SPT was more potent here than has previously been demonstrated.This publication has 20 references indexed in Scilit:
- Is there a basis for distinguishing two types of P2-purinoceptor?Published by Elsevier ,2002
- Role of adenine compounds in autonomic neurotransmissionPharmacology & Therapeutics, 1988
- Indications for P2-purinoceptor subtypes in guinea pig smooth muscleEuropean Journal of Pharmacology, 1988
- Adenosine 5′-(2-fluorodiphosphate) is a selective agonist at P2-purinoceptors mediating relaxation of smooth muscleEuropean Journal of Pharmacology, 1988
- Agonist and antagonist characterization of the P2‐purinoceptors in the guinea pig ileumActa Physiologica Scandinavica, 1988
- The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potencyEuropean Journal of Pharmacology, 1987
- Pharmacological effects of L-AMP-PCP on ATP receptors in smooth muscleEuropean Journal of Pharmacology, 1986
- ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptorEuropean Journal of Pharmacology, 1986
- L-AMP-PCP, an ATP receptor agonist in guinea-pig bladder, is inactive on taenia coliEuropean Journal of Pharmacology, 1985
- γ-Fluoroadenosine triphosphate. Synthesis, properties, and interaction with myosin and heavy meromyosinBiochemistry, 1972